Novartis multiple sclerosis drug cuts relapse rates by a third in pivotal trials
Novartis's multiple sclerosis treatment remibrutinib cut relapse rates by a third compared with a standard treatment in…
1 post ·Searches every conversation and article, Mister Translation, Eight Miles West and the Ledger's live boards.
Mix them: “site:youtube.com sourdough -keto”. The other sites in the results match the words only.Search tips
"roman concrete"jaguar -carbitcoin OR ethereumsite:youtube.com sourdoughfiletype:pdf tax formhas:photo has:video has:audio has:linkin:places tokyofrom:@name recipeafter:2026-10-01 before:2026-10-15
✨ OverviewAI Reading the conversations…
Novartis's multiple sclerosis treatment remibrutinib cut relapse rates by a third compared with a standard treatment in…
1 post ·…If that molecule name sounds familiar it is because it is the same one Novartis has sold since…
Article ·